Molecular characterisation of human rabies in Tanzania and Kenya: a case series report and phylogenetic investigation.


Journal

Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645

Informations de publication

Date de publication:
28 Oct 2024
Historique:
received: 27 06 2024
accepted: 17 09 2024
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

Rabies remains a major public health problem in low- and middle-income countries. However, human rabies deaths are rarely laboratory-confirmed or sequenced, especially in Africa. Five human rabies deaths from Tanzania and Kenya were investigated and the causative rabies viruses sequenced, with the aim of identifying implications for rabies control at individual, healthcare and societal levels. The epidemiological context and care of these cases was contrasting. Four had a clear history of being bitten by dogs, while one had an unclear biting history. Two individuals sought medical attention within a day of being bitten, whereas three sought care only after developing rabies symptoms. Despite seeking medical care, none of the cases received complete post-exposure prophylaxis: one patient received only tetanus vaccination, one did not complete the post-exposure vaccination regimen, one followed an off-label vaccination schedule, and two did not receive any post-exposure vaccinations before the onset of symptoms. These cases highlight serious gaps in health-seeking behaviour, and in health systems providing appropriate care following risky exposures, including in the accessibility and effectiveness of post-exposure prophylaxis as it is administered in the region. The viral genomic and epidemiological data confirms dog-mediated rabies as the cause of each of these deaths. The phylogenetic investigation highlights the transboundary circulation of rabies within domestic dog populations, revealing distinct rabies virus clades with evidence of regional spread. These findings underscore the importance of coordinated cross-border control efforts between the two countries. Urgent action is needed to improve awareness around the need for emergency post-exposure vaccines that should be accessible in local communities and administered appropriately, as well as investment in coordinated dog vaccination to control dog-mediated rabies, the underlying cause of these deaths.

Sections du résumé

BACKGROUND BACKGROUND
Rabies remains a major public health problem in low- and middle-income countries. However, human rabies deaths are rarely laboratory-confirmed or sequenced, especially in Africa. Five human rabies deaths from Tanzania and Kenya were investigated and the causative rabies viruses sequenced, with the aim of identifying implications for rabies control at individual, healthcare and societal levels.
CASE PRESENTATION METHODS
The epidemiological context and care of these cases was contrasting. Four had a clear history of being bitten by dogs, while one had an unclear biting history. Two individuals sought medical attention within a day of being bitten, whereas three sought care only after developing rabies symptoms. Despite seeking medical care, none of the cases received complete post-exposure prophylaxis: one patient received only tetanus vaccination, one did not complete the post-exposure vaccination regimen, one followed an off-label vaccination schedule, and two did not receive any post-exposure vaccinations before the onset of symptoms. These cases highlight serious gaps in health-seeking behaviour, and in health systems providing appropriate care following risky exposures, including in the accessibility and effectiveness of post-exposure prophylaxis as it is administered in the region.
CONCLUSIONS CONCLUSIONS
The viral genomic and epidemiological data confirms dog-mediated rabies as the cause of each of these deaths. The phylogenetic investigation highlights the transboundary circulation of rabies within domestic dog populations, revealing distinct rabies virus clades with evidence of regional spread. These findings underscore the importance of coordinated cross-border control efforts between the two countries. Urgent action is needed to improve awareness around the need for emergency post-exposure vaccines that should be accessible in local communities and administered appropriately, as well as investment in coordinated dog vaccination to control dog-mediated rabies, the underlying cause of these deaths.

Identifiants

pubmed: 39468631
doi: 10.1186/s40249-024-01245-w
pii: 10.1186/s40249-024-01245-w
doi:

Substances chimiques

Rabies Vaccines 0

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

79

Subventions

Organisme : Wellcome Trust
ID : 207569/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 224670/Z/21/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110330
Pays : United Kingdom
Organisme : National Institute for Health and Care Research, Global Health Research Group on the Application of Genomics and Modelling to the Control of Virus Pathogens (GeMVi) in East Africa at the University of Warwickellowship
ID : 176382
Organisme : Wellcome Trust
ID : 204820
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/X002047/1
Pays : United Kingdom

Informations de copyright

© 2024. The Author(s).

Références

World Health Organisation. Rabies vaccine: WHO position paper. Wkly Epidemiol Rec. 2018;16:201–20.
Hampson K, Ventura F, Steenson R, Mancy R, Trotter C, Cooper L, et al. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study. Lancet Infect Dis. 2019;19:102–11. https://doi.org/10.1016/S1473-3099(18)30512-7 .
doi: 10.1016/S1473-3099(18)30512-7
Thiptara A, Atwill ER, Kongkaew W, Chomel BB. Epidemiologic trends of rabies in domestic animals in southern Thailand, 1994–2008. Am J Trop Med Hyg. 2011;85:138–45. https://doi.org/10.4269/ajtmh.2011.10-0535 .
doi: 10.4269/ajtmh.2011.10-0535 pubmed: 21734139 pmcid: 3122358
Nel LH. Discrepancies in data reporting for rabies. Africa Emerg Infect Dis. 2013;19:529–33. https://doi.org/10.3201/eid1904.120185 .
doi: 10.3201/eid1904.120185 pubmed: 23628197
Fooks AR, Banyard AC, Horton DL, Johnson N, McElhinney LM, Jackson AC. Current status of rabies and prospects for elimination. Lancet. 2014;384:1389–99. https://doi.org/10.1016/S0140-6736(13)62707-5 .
doi: 10.1016/S0140-6736(13)62707-5 pubmed: 24828901 pmcid: 7159301
Rasooli A, Pourhossein B, Bashar R, Shirzadi MR, Amiri B, Kheiri EV, et al. Investigating possible etiologies of post-exposure prophylaxis failure and deaths from rabies infection: case reports. Int J Med Toxicol Forens Med. 2020;10:27378–27378. https://doi.org/10.32598/ijmtfm.v10i3.27378 .
doi: 10.32598/ijmtfm.v10i3.27378
World Health Organisation. WHO Expert Consultation on Rabies.World Health Organization technical report series. 2018. https://www.who.int/publications/i/item/WHO-TRS-1012 .
Thumbi SM, Blumberg L, le Roux K, Salahuddin N, Abela B. A call to accelerate an end to human rabies deaths. Lancet. 2023;400:2261–4. https://doi.org/10.1016/S0140-6736(22)02487-4 .
doi: 10.1016/S0140-6736(22)02487-4
Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet. 2004;363:959–69. https://doi.org/10.1016/S0140-6736(04)15792-9 .
doi: 10.1016/S0140-6736(04)15792-9 pubmed: 15043965
Changalucha J, Steenson R, Grieve E, Cleaveland S, Lembo T, Lushasi K, et al. The need to improve access to rabies post-exposure vaccines: lessons from Tanzania. Vaccine. 2019;37:A45–53. https://doi.org/10.1016/j.vaccine.2018.08.086 .
doi: 10.1016/j.vaccine.2018.08.086 pubmed: 30309746 pmcid: 6863039
Soun VV, Eidson M, Wallace BJ, Drabkin PD, Jones G, Leach R, et al. Antemortem diagnosis of New York human rabies case and review of U.S. Cases. Int J Biomed Sci. 2006;2:434–45.
pubmed: 23675013 pmcid: 3614649
Madhusudana SN, Sukumaran SM. Antemortem diagnosis and prevention of human rabies. Ann Indian Acad Neurol. 2008;11:3–12. https://doi.org/10.4103/0972-2327.40219 .
doi: 10.4103/0972-2327.40219 pubmed: 19966972 pmcid: 2781142
Talbi C, Lemey P, Suchard MA, Abdelatif E, Elharrak M, Jalal N, et al. Phylodynamics and human-mediated dispersal of a zoonotic virus. PLOS Pathog. 2010;6: e1001166. https://doi.org/10.1371/journal.ppat.1001166 .
doi: 10.1371/journal.ppat.1001166 pubmed: 21060816 pmcid: 2965766
Trewby H, Nadin-Davis SA, Real LA, Biek R. Processes underlying rabies virus incursions across US–Canada Border as revealed by whole-genome phylogeography. Emerg Infect Dis. 2017;23:1454–61. https://doi.org/10.3201/eid2309.170325 .
doi: 10.3201/eid2309.170325 pubmed: 28820138 pmcid: 5572885
Lushasi K, Brunker K, Rajeev M, Ferguson EA, Jaswant G, Baker LL, et al. Integrating contact tracing and whole-genome sequencing to track the elimination of dog-mediated rabies: an observational and genomic study. Elife. 2023;12: e85262. https://doi.org/10.7554/eLife.85262 .
doi: 10.7554/eLife.85262 pubmed: 37227428 pmcid: 10299823
Layan M, Dellicour S, Baele G, Cauchemez S, Bourhy H. Mathematical modelling and phylodynamics for the study of dog rabies dynamics and control: a scoping review. PLoS Negl Trop Dis. 2021;15: e0009449. https://doi.org/10.1371/journal.pntd.0009449 .
doi: 10.1371/journal.pntd.0009449 pubmed: 34043640 pmcid: 8189497
McElhinney LM, Marston DA, Golding M, Nadin-Davis SA. Chapter 12 - Laboratory diagnosis of rabies. In: Fooks AR, Jackson AC, editors. rabies. 4th ed. Boston: Academic Press; 2020. p. 401–44.
doi: 10.1016/B978-0-12-818705-0.00012-1
Mollentze N, Weyer J, Markotter W, le Roux K, Nel LH. Dog rabies in southern Africa: regional surveillance and phylogeographical analyses are an important component of control and elimination strategies. Virus Genes. 2013;47:569–73. https://doi.org/10.1007/s11262-013-0974-3 .
doi: 10.1007/s11262-013-0974-3 pubmed: 23996607
Coetzee P, Weyer J, Paweska JT, Burt FJ, Markotter W, Nel LH. Use of a molecular epidemiological database to track human rabies case histories in South Africa. Epidemiol Infect. 2008;136:1270–6. https://doi.org/10.1017/S0950268807009582 .
doi: 10.1017/S0950268807009582 pubmed: 17961278
Faye M, Faye O, Paola ND, Ndione MHD, Diagne MM, Diagne CT, et al. Rabies surveillance in Senegal 2001 to 2015 uncovers first infection of a honey-badger. Transbound Emerg Dis. 2022;69:e1350–64. https://doi.org/10.1111/tbed.14465 .
doi: 10.1111/tbed.14465 pubmed: 35124899
Ogo MF, Nel LH, Sabeta CT. Phylogenetic evidence of the public and veterinary health threat of dog rabies in Nigeria. Nig Vet J. 2011. https://doi.org/10.4314/nvj.v32i1.68996 .
doi: 10.4314/nvj.v32i1.68996
Hampson K, Dobson A, Kaare M, Dushoff J, Magoto M, Sindoya E, et al. Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Dis. 2008;2: e339. https://doi.org/10.1371/journal.pntd.0000339 .
doi: 10.1371/journal.pntd.0000339 pubmed: 19030223 pmcid: 2582685
Bautista C, Jaswant G, French H, Campbell K, Durrant R, Gifford R, et al. Whole genome sequencing for rapid characterization of rabies virus using nanopore technology. J Vis Exp. 2023. https://doi.org/10.3791/65414 .
doi: 10.3791/65414 pubmed: 37677046
Wentworth D, Hampson K, Thumbi SM, Mwatondo A, Wambura G, Rui N. A social justice perspective on access to human rabies vaccines. Vaccine. 2019. https://doi.org/10.1016/j.vaccine.2019.01.065 .
doi: 10.1016/j.vaccine.2019.01.065 pubmed: 31326251 pmcid: 7612384
Rupprecht CE, Fooks AR, Abela-Ridder B. Laboratory techniques in rabies. 5th ed. World Health Organization: Geneva; 2019.
Lembo T, Niezgoda M, Velasco-Villa A, Cleaveland S, Ernest E, Rupprecht CE. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis. 2006;12:310–3. https://doi.org/10.3201/eid1202.050812 .
doi: 10.3201/eid1202.050812 pubmed: 16494761 pmcid: 3294322
Coetzer A, Nel LH, Taylor L. Direct, Rapid Immunohistochemical Test (DRIT). Global Alliance for Rabies Control; 2017. https://rabiesalliance.org/resource/direct-rapid-immunohistochemistry-test-drit-manual . Accessed 20 Jun 2024.
Klein A, Fahrion A, Finke S, Eyngor M, Novak S, Yakobson B, et al. Further evidence of inadequate quality in lateral flow devices commercially offered for the diagnosis of rabies. Trop Med Infect Dis. 2020;5:13. https://doi.org/10.3390/tropicalmed5010013 .
doi: 10.3390/tropicalmed5010013 pubmed: 31963635 pmcid: 7157750
Eggerbauer E, de Benedictis P, Hoffmann B, Mettenleiter TC, Schlottau K, Ngoepe EC, et al. Evaluation of six commercially available rapid immunochromatographic tests for the diagnosis of rabies in brain material. PLoS Negl Trop Dis. 2016;10: e0004776. https://doi.org/10.1371/journal.pntd.0004776 .
doi: 10.1371/journal.pntd.0004776 pubmed: 27336943 pmcid: 4918935
Mauti S, Léchenne M, Naïssengar S, Traoré A, Kallo V, Kouakou C, et al. Field postmortem rabies rapid immunochromatographic diagnostic test for resource-limited settings with further molecular applications. J Vis Exp. 2020. https://doi.org/10.3791/60008 .
doi: 10.3791/60008 pubmed: 32658185
Léchenne M, Naïssengar K, Lepelletier A, Alfaroukh IO, Bourhy H, Zinsstag J, et al. Validation of a rapid rabies diagnostic tool for field surveillance in developing countries. PLoS Negl Trop Dis. 2016;10: e0005010. https://doi.org/10.1371/journal.pntd.0005010 .
doi: 10.1371/journal.pntd.0005010 pubmed: 27706156 pmcid: 5051951
Cantaert T, Borand L, Kergoat L, Leng C, Ung S, In S, et al. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study. Lancet Infect Dis. 2019;19:1355–62. https://doi.org/10.1016/S1473-3099(19)30311-1 .
doi: 10.1016/S1473-3099(19)30311-1 pubmed: 31570311
Nadal D, Bote K, Masthi R, Narayana A, Ross Y, Wallace R, et al. Rabies post-exposure prophylaxis delivery to ensure treatment efficacy and increase compliance. JID One Health. 2023;1: 100006. https://doi.org/10.1016/j.ijidoh.2023.100006 .
doi: 10.1016/j.ijidoh.2023.100006
Mancy R, Rajeev M, Lugelo A, Brunker K, Cleaveland S, Ferguson EA, et al. Rabies shows how scale of transmission can enable acute infections to persist at low prevalence. Science. 2022;376:512–6. https://doi.org/10.1126/science.abn0713 .
doi: 10.1126/science.abn0713 pubmed: 35482879 pmcid: 7613728
Hampson K, Dushoff J, Cleaveland S, Haydon DT, Kaare M, Packer C, et al. Transmission dynamics and prospects for the elimination of canine Rabies. PLoS Biol. 2009;7:0462–71. https://doi.org/10.1371/journal.pbio.1000053 .
doi: 10.1371/journal.pbio.1000053
Lushasi K, Hayes S, Ferguson EA, Changalucha J, Cleaveland S, Govella NJ, et al. Reservoir dynamics of rabies in south-east Tanzania and the roles of cross-species transmission and domestic dog vaccination. J Appl Ecol. 2021;58:2673–85. https://doi.org/10.1111/1365-2664.13983 .
doi: 10.1111/1365-2664.13983 pubmed: 35221371 pmcid: 7612421
Lembo T, Hampson K, Kaare MT, Ernest E, Knobel D, Kazwala RR, et al. The feasibility of canine rabies elimination in africa: dispelling doubts with data. PLoS Negl Trop Dis. 2010;4: e626. https://doi.org/10.1371/journal.pntd.0000626 .
doi: 10.1371/journal.pntd.0000626 pubmed: 20186330 pmcid: 2826407
Minghui R, Stone M, Semedo MH, Nel L. New global strategic plan to eliminate dog-mediated rabies by 2030. Lancet Global Health. 2018;6:e828–9. https://doi.org/10.1016/S2214-109X(18)30302-4 .
doi: 10.1016/S2214-109X(18)30302-4 pubmed: 29929890

Auteurs

Gurdeep Jaswant (G)

Faculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya. gurdeepjaswant14@gmail.com.
School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK. gurdeepjaswant14@gmail.com.
Food Biotechnology & Microbiology, Tanzania Industrial Research Development Organization, Dar Es Salaam, 14111, Tanzania. gurdeepjaswant14@gmail.com.
Environmental Health & Ecological Sciences, Ifakara Health Institute, Plot 463, Dar Es Salaam, Tanzania. gurdeepjaswant14@gmail.com.

Kathryn Campbell (K)

School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.

Anna Czupryna (A)

School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
Environmental Health & Ecological Sciences, Ifakara Health Institute, Plot 463, Dar Es Salaam, Tanzania.

Athman Mwatondo (A)

Zoonotic Disease Unit, Ministry of Health and Ministry of Livestock, Nairobi, 00202, Kenya.

Brian Ogoti (B)

Faculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya.
Center for Epidemiological Modelling & Analysis, University of Nairobi, Nairobi, 00202, Kenya.

Carmen W E Embregts (CWE)

Viroscience Department, Erasmus MC Rotterdam, Rotterdam, 3015 CN, the Netherlands.

Corine H GeurtsvanKessel (CH)

Viroscience Department, Erasmus MC Rotterdam, Rotterdam, 3015 CN, the Netherlands.

Charles Kayuki (C)

Oxford Nanopore Technologies, Gosling Building, Edmund Halley Road, Oxford Science Park, Oxford, OX4 4DQ, UK.

Davis Kuchaka (D)

Biotechnology Laboratory, Kilimanjaro Clinical Research Institute, P. O. Box 2236, Moshi, Tanzania.

Gati Wambura (G)

Center for Global Health Research, Kenya Medical Research Institute, Kisumu, 40100, Kenya.

James Oigo (J)

Center for Global Health Research, Kenya Medical Research Institute, Kisumu, 40100, Kenya.

Joel Changalucha (J)

Environmental Health & Ecological Sciences, Ifakara Health Institute, Plot 463, Dar Es Salaam, Tanzania.
Tanzania College of Veterinary Medicine & Biomedical Science, Sokoine University of Agriculture, Morogoro, 67804, Tanzania.

Julius O Oyugi (JO)

Faculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya.
Department of Medical Microbiology, Faculty of Health Sciences, University of Nairobi, Nairobi, 00202, Kenya.

Kennedy Lushasi (K)

Environmental Health & Ecological Sciences, Ifakara Health Institute, Plot 463, Dar Es Salaam, Tanzania.

Lwitiko Sikana (L)

Environmental Health & Ecological Sciences, Ifakara Health Institute, Plot 463, Dar Es Salaam, Tanzania.

Marco van Zwetselaar (M)

Biotechnology Laboratory, Kilimanjaro Clinical Research Institute, P. O. Box 2236, Moshi, Tanzania.

Marieke C J Dekker (MCJ)

Biotechnology Laboratory, Kilimanjaro Clinical Research Institute, P. O. Box 2236, Moshi, Tanzania.

Mathew Muturi (M)

Zoonotic Disease Unit, Ministry of Health and Ministry of Livestock, Nairobi, 00202, Kenya.

Marybeth Maritim (M)

Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, 00202, Kenya.

Mumbua Mutunga (M)

Faculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya.
Center for Epidemiological Modelling & Analysis, University of Nairobi, Nairobi, 00202, Kenya.

Rowan Durrant (R)

School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.

Tom Abala (T)

Center for Global Health Research, Kenya Medical Research Institute, Kisumu, 40100, Kenya.

Veronicah Chuchu (V)

Center for Epidemiological Modelling & Analysis, University of Nairobi, Nairobi, 00202, Kenya.
Paul G Allen School for Global Health, Washington State University, 1155 NE College Ave, Pullman, WA, 99164, USA.

Kirstyn Brunker (K)

School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.

S M Thumbi (SM)

Faculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya.
Center for Epidemiological Modelling & Analysis, University of Nairobi, Nairobi, 00202, Kenya.
Paul G Allen School for Global Health, Washington State University, 1155 NE College Ave, Pullman, WA, 99164, USA.
Institute of Immunology & Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, EH9 3FL, Scotland, UK.

Katie Hampson (K)

School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH